Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Triple negative breast cancer: Which Medications Are Safest? (200 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

200 medications are used for Triple negative breast cancer, with 10,959 combined adverse event reports. The most reported drugs for Triple negative breast cancer are PEMBROLIZUMAB and PACLITAXEL.

10,959
Total Reports
200
Drugs Used

All Medications for Triple negative breast cancer Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
PEMBROLIZUMAB KEYTRUDA 5,148 15,543 35,472 18.6%
PACLITAXEL PACLITAXEL PACLITAXEL 3,863 12,030 31,638 15.6%
CARBOPLATIN Carboplatin 3,195 12,544 35,869 14.9%
CYCLOPHOSPHAMIDE Cyclophosphamide 1,933 25,330 45,054 19.7%
ATEZOLIZUMAB Tecentriq Hybreza 1,393 8,520 15,094 25.3%
SACITUZUMAB GOVITECAN-HZIY - 1,386 796 868 21.6%
EPIRUBICIN Ellence 1,087 2,212 5,603 13.6%
DOXORUBICIN Doxorubicin Hydrochloride 967 15,653 28,630 18.9%
DOCETAXEL Docetaxel 691 6,068 13,463 9.3%
SACITUZUMAB GOVITECAN TRODELVY 650 353 530 28.0%
CAPECITABINE Capecitabine 430 8,892 17,529 14.0%
GEMCITABINE Gemcitabine 351 5,142 12,268 16.4%
BEVACIZUMAB JOBEVNE 180 17,498 23,114 22.4%
ERIBULIN eribulin mesylate 171 793 2,642 15.7%
FLUOROURACIL FLUOROURACIL 107 6,997 20,941 13.2%
OLAPARIB Lynparza 98 5,496 3,471 30.1%
NIVOLUMAB OPDIVO 83 23,086 36,530 26.3%
PEGFILGRASTIM ZIEXTENZO 71 2,367 7,050 2.9%
VELIPARIB - 67 43 222 11.0%
DURVALUMAB IMFINZI 47 5,088 5,968 29.7%

View all 200 drugs →

Most Reported Drugs for Triple negative breast cancer

#1 most reported
#2 most reported
#3 most reported